Literature DB >> 34341170

Expansion of Unique Hepatitis C Virus-Specific Public CD8+ T Cell Clonotypes during Acute Infection and Reinfection.

Sabrina Mazouz1,2, Maude Boisvert1, Mohamed S Abdel-Hakeem1,2, Omar Khedr1, Julie Bruneau1,3, Naglaa H Shoukry4,5.   

Abstract

Hepatitis C virus (HCV) infection resolves spontaneously in ∼25% of acutely infected humans where viral clearance is mediated primarily by virus-specific CD8+ T cells. Previous cross-sectional analysis of the CD8+ TCR repertoire targeting two immunodominant HCV epitopes reported widespread use of public TCRs shared by different subjects, irrespective of infection outcome. However, little is known about the evolution of the public TCR repertoire during acute HCV and whether cross-reactivity to other Ags can influence infectious outcome. In this article, we analyzed the CD8+ TCR repertoire specific to the immunodominant and cross-reactive HLA-A2-restricted nonstructural 3-1073 epitope during acute HCV in humans progressing to either spontaneous resolution or chronic infection and at ∼1 y after viral clearance. TCR repertoire diversity was comparable among all groups with preferential usage of the TCR-β V04 and V06 gene families. We identified a set of 13 public clonotypes in HCV-infected humans independent of infection outcome. Six public clonotypes used the V04 gene family. Several public clonotypes were long-lived in resolvers and expanded on reinfection. By mining publicly available data, we identified several low-frequency CDR3 sequences in the HCV-specific repertoire matching human TCRs specific for other HLA-A2-restricted epitopes from melanoma, CMV, influenza A, EBV, and yellow fever viruses, but they were of low frequency and limited cross-reactivity. In conclusion, we identified 13 new public human CD8+ TCR clonotypes unique to HCV that expanded during acute infection and reinfection. The low frequency of cross-reactive TCRs suggests that they are not major determinants of infectious outcome.
Copyright © 2021 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34341170      PMCID: PMC8434894          DOI: 10.4049/jimmunol.2001386

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  46 in total

1.  Linking the T cell receptor to the single cell transcriptome in antigen-specific human T cells.

Authors:  Auda A Eltahla; Simone Rizzetto; Mehdi R Pirozyan; Brigid D Betz-Stablein; Vanessa Venturi; Katherine Kedzierska; Andrew R Lloyd; Rowena A Bull; Fabio Luciani
Journal:  Immunol Cell Biol       Date:  2016-02-10       Impact factor: 5.126

2.  Sequence and Structural Analyses Reveal Distinct and Highly Diverse Human CD8+ TCR Repertoires to Immunodominant Viral Antigens.

Authors:  Guobing Chen; Xinbo Yang; Annette Ko; Xiaoping Sun; Mingming Gao; Yongqing Zhang; Alvin Shi; Roy A Mariuzza; Nan-Ping Weng
Journal:  Cell Rep       Date:  2017-04-18       Impact factor: 9.423

3.  Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C.

Authors:  A Takaki; M Wiese; G Maertens; E Depla; U Seifert; A Liebetrau; J L Miller; M P Manns; B Rehermann
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

4.  Lack of Heterologous Cross-reactivity toward HLA-A*02:01 Restricted Viral Epitopes Is Underpinned by Distinct αβT Cell Receptor Signatures.

Authors:  Emma J Grant; Tracy M Josephs; Sophie A Valkenburg; Linda Wooldridge; Margaret Hellard; Jamie Rossjohn; Mandvi Bharadwaj; Katherine Kedzierska; Stephanie Gras
Journal:  J Biol Chem       Date:  2016-09-19       Impact factor: 5.157

5.  Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells.

Authors:  H Wedemeyer; E Mizukoshi; A R Davis; J R Bennink; B Rehermann
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  SPICE: exploration and analysis of post-cytometric complex multivariate datasets.

Authors:  Mario Roederer; Joshua L Nozzi; Martha C Nason
Journal:  Cytometry A       Date:  2011-01-07       Impact factor: 4.355

7.  Defining the directionality and quality of influenza virus-specific CD8+ T cell cross-reactivity in individuals infected with hepatitis C virus.

Authors:  Victoria Kasprowicz; Scott M Ward; Alison Turner; Alexandros Grammatikos; Brian E Nolan; Lia Lewis-Ximenez; Charles Sharp; Jenny Woodruff; Vicki M Fleming; Stuart Sims; Bruce D Walker; Andrew K Sewell; Georg M Lauer; Paul Klenerman
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

8.  A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.

Authors:  Kristin Ladell; Masao Hashimoto; Maria Candela Iglesias; Pascal G Wilmann; James E McLaren; Stéphanie Gras; Takayuki Chikata; Nozomi Kuse; Solène Fastenackels; Emma Gostick; John S Bridgeman; Vanessa Venturi; Zaïna Aït Arkoub; Henri Agut; David J van Bockel; Jorge R Almeida; Daniel C Douek; Laurence Meyer; Alain Venet; Masafumi Takiguchi; Jamie Rossjohn; David A Price; Victor Appay
Journal:  Immunity       Date:  2013-03-21       Impact factor: 31.745

9.  Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape.

Authors:  Dirk Meyer-Olson; Naglaa H Shoukry; Kristen W Brady; Helen Kim; Douglas P Olson; Kelly Hartman; Ayumi K Shintani; Christopher M Walker; Spyros A Kalams
Journal:  J Exp Med       Date:  2004-08-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.